> News
 > Interview of Hervé Affagard, President of EMIH
News
21/02/2025

Interview of Hervé Affagard, President of EMIH

We caught up with Hervé Affagard, CEO of MaaT Pharma and President of EMIH for an exclusive interview to discuss the far reaching impact of the ARES Phase 3 unprecedented results

Read the full interview below.

Register to Microbiome Times Partnering Forum: https://www.microbiomeforum.com/register

Our news

News
04/09/2025
MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline
> READ
News
14/05/2024
The Alliance Promotion Microbiote is becoming the European Microbiome Innovation for Health: a major step towards structuring the European microbiome excellence sector
> READ
News
21/03/2025
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS)
> READ
> See all news

EMIH has launched Europe’s First AI & Microbiome Bootcamp